Cargando…

Characterization of B cells in synovial fluid and tissue from patients with JIA

Detalles Bibliográficos
Autores principales:	Ferlito, F, Corcione, A, Traggiai, E, Gregorio, A, Martini, A, Pistoia, V, Gattorno, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334014/ http://dx.doi.org/10.1186/1546-0096-6-S1-P21

Ejemplares similares

Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis
por: Corcione, Anna, et al.
Publicado: (2009)

The role of synovial fluid cytokines IL-6, IL-23 and IL-17 in the pathogenesis and persistence of synovial inflammation in JIA patients
por: Tzimouli, V, et al.
Publicado: (2008)

Osteoblast differentiation from synovial fluid cells in juvenile idiopathic arthritis (JIA)
por: Jelusic-Drazic, Marija, et al.
Publicado: (2012)

B cell subsets phenotype in autoimmunity with immunodeficiency: analysis of a cohort of patients with APECED syndrome
por: Magnani, A, et al.
Publicado: (2011)

B cells characterization in ADA2 Deficiency patients
por: Schena, F, et al.
Publicado: (2015)

PD-1/PD-L1 signaling in JIA synovial regulatory T cell function
por: de Roock, Sytze, et al.
Publicado: (2011)

YIM-P44. Reduced expression of cd73 on jia synovial lymphocytes is related to cell proliferation
por: Gordon-Smith, Sophie Botta, et al.
Publicado: (2014)

Different pattern of synthesis and secretion of IL-1beta in patients with CIAS-1 and TNFRSF1A mutations responding to IL-1 blockade
por: Lasigliè, D, et al.
Publicado: (2008)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
por: Verazza, S, et al.
Publicado: (2008)

MEFV mutations in systemic JIA
por: Aktay Ayaz, N, et al.
Publicado: (2008)

Accuracy of preliminary remission criteria some JIA category
por: Fantini, F, et al.
Publicado: (2008)

Mesenchymal stem cells and JIA
por: Swart, JF, et al.
Publicado: (2011)

Over expression of toll-like receptors in peripheral blood and synovial fluid monocytes of enthesitis related arthritis category of juvenile idiopathic arthritis (JIA-ERA) patients contributes to secretion of inflammatory mediators
por: Myles, Arpita, et al.
Publicado: (2012)

A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials
por: Demirkaya, E, et al.
Publicado: (2011)

JIA affected sibling pairs present high correlation for ANA and ILAR category
por: Filocamo, G, et al.
Publicado: (2011)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
por: Filocamo, G, et al.
Publicado: (2008)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
por: Lattanzi, B, et al.
Publicado: (2008)

The swedish paediatric JIA-registry
por: Magnusson, Bo
Publicado: (2014)

Puberty and disease activity in JIA
por: Van Pelt, Philomine, et al.
Publicado: (2014)

Clinical classification of JIA in Albania
por: Vula, Aurel, et al.
Publicado: (2014)

Effects of anti-rheumatic treatments on the prostaglandin E(2 )biosynthetic pathway in synovial tissue and synovial fluid cells from patients with rheumatoid arthritis
por: Korotkova, M, et al.
Publicado: (2005)

Ultrasound guided joint fluid aspiration and corticosteroid injection in patients with juvenile idiopathic arthritis (JIA)
por: Heuck, C, et al.
Publicado: (2008)

Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis
por: McGonagle, D, et al.
Publicado: (2003)

Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship?
por: Rossi, L, et al.
Publicado: (2008)

Ocular threat in juvenile idiopathic arthritis (JIA)
por: Marvillet, I, et al.
Publicado: (2008)

Determing an “autoimmune” phenotype in systemic JIA
por: Fischer, N, et al.
Publicado: (2011)

Adverse events of methotrexate treatment in JIA
por: in ‘t Veld, J, et al.
Publicado: (2011)

Evaluation of the JIA treatment with adalimumab in ukraine
por: Ponochevna, Elena, et al.
Publicado: (2014)

Effect of ANA positivity on clinical picture of the JIA: should ANA positive JIA be classified as a different group?
por: Polat, Adem, et al.
Publicado: (2011)

Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA)
por: Magnani, A, et al.
Publicado: (2008)

Neuroblastoma versus systemic JIA – a diagnostic dilemma
por: Scalzi, Lisabeth, et al.
Publicado: (2012)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
por: Davì, S, et al.
Publicado: (2008)

Changes in articular cartilage thickness of the knee in JIA as assessed by ultrasonography
por: Pradsgaard, D, et al.
Publicado: (2011)

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
por: Lu, P, et al.
Publicado: (2013)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
por: Officioso, A, et al.
Publicado: (2011)

Use of internet in adolescents and young adults with JIA
por: Van Pelt, Philomine, et al.
Publicado: (2014)

JIA-like in a boy with Ataxia-telangiectasia
por: Furtado, Filipa, et al.
Publicado: (2014)

PReS-FINAL-2055: Is there a necessity for patients with JIA to wear orthopedic insoles?
por: Kreuzpointner, F, et al.
Publicado: (2013)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_v6p63m2koc72mchkmneq6k9c1o